Effectiveness of Oral Magnesium Supplementation in Fibromyalgia Patients Not Responding to Standard Treatment

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Fibromyalgia

In brief

Fibromyalgia is a complex widespread pain disorder. OBJECTIVES To evaluate the effectiveness of oral magnesium supplementation in reducing symptom severity among fibromyalgia patients who have not responded to standard treatment, using validated scoring systems such as the Fibromyalgia Impact Questionnaire Revised (FIQR).

Key facts

Study ID

NCT07585045

Run by

Shaikh Zayed Hospital, Lahore

People needed

86

Starts

2026-04-16

Expected to finish

2027-02-26

Last updated by the study team

2026-05-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with FM according to the American College of Rheumatology (ACR) 2016 criteria
• Age: 18-65 years.
• Not responding to conventional treatment (e.g., amitriptyline, duloxetine, pregabalin) for at least 8 weeks
• Patients giving informed consent for enrollment in the study.

You may not qualify if…

• 1- Patients with renal impairment 2- Pregnant or lactating women 3- Already on magnesium or other mineral supplements 4- Known cases of inflammatory arthritis or other chronic pain syndromes

Where it is running

• Shaikh Zayed Hospital, Lahore — Lahore, Punjab Province, Pakistan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.